Moreover, in addition to ki67 and p27, researchers also consider other markers to focus on specific proportions of QCCs, e.g., Yes and YAP [41] or SOX9 [42], revealing the diversity of QCCs across different conditions (e.g., primary site, distant metastatic site, cancer type, or specific genomic signature). The gene discussed is CDKN1B; the disease is cancer.